Vir Biotechnology (NASDAQ:VIR) PT Raised to $12 00 at JPMorgan Chase & Co themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Vir Biotechnology (NASDAQ:VIR) Rating Reiterated by Needham & Company LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $9.18, but opened at $10.13. Vir Biotechnology shares last traded at $10.21, with a volume of 527,255 shares. The company reported ($0.48) earnings per share for the […]
– Late-breaker SOLSTICE data abstract accepted for poster presentation at the European Association for the Study of the Liver Congress 2024 –
– Two additional hepatitis program data readouts.